Cardiac Assessment of Patients With Type 1 Diabetes Median 10 Years After Successful Simultaneous Pancreas and Kidney Transplantation Compared With Living Donor Kidney Transplantation
Authors:
- Jørn Petter LindahlJLJørn Petter Lindahl
- Richard John MasseyRichard John Massey
- Anders HartmannAnders Hartmann
- Svend AakhusSvend Aakhus
- Knut EndresenKnut Endresen
- Anne GüntherAnne Günther
- Karsten MidtvedtKarsten Midtvedt
- Hallvard HoldaasHallvard Holdaas
- Torbjørn LeivestadTLTorbjørn Leivestad
- Rune HornelandRHRune Horneland
- Ole ØyenOle Øyen
- Trond JenssenTrond Jenssen
- 1 June 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 101 (6) , 1261-1267
Abstract
In recipients with type 1 diabetes, we aimed to determine whether long-term normoglycemia achieved by successful simultaneous pancreas and kidney (SPK) transplantation could beneficially affect progression of coronary artery disease (CAD) when compared with transplantation of a kidney-alone from a living donor (LDK). In 42 kidney transplant recipients with functioning grafts who had received either SPK (n = 25) or LDK (n = 17), we studied angiographic progression of CAD between baseline (pretransplant) and follow-up at 7 years or older. In addition, computed tomography scans for measures of coronary artery calcification and echocardiographic assessment of left ventricular systolic function were addressed at follow-up. During a median follow-up time of 10.1 years (interquartile range [IQR], 9.1-11.5) progression of CAD occurred at similar rates (10 of 21 cases in the SPK and 5 of 14 cases in the LDK group; P = 0.49). Median coronary artery calcification scores were high in both groups (1767 [IQR, 321-4035] for SPK and 1045 [IQR, 807-2643] for LDK patients; P = 0.59). Left ventricular systolic function did not differ between the 2 groups. The SPK and LDK recipients were similar in age (41.2 ± 6.9 years vs 40.5 ± 10.3 years; P = 0.80) and diabetes duration at engraftment but with significant different mean HbA1c levels of 5.5 ± 0.4% for SPK and 8.3 ± 1.5% for LDK patients (P Conclusions In patients with both type 1 diabetes and end-stage renal disease, SPK recipients had similar progression of CAD long-term compared with LDK recipients. Calcification of coronary arteries is a prominent feature in both groups long-term posttransplant.Keywords
This publication has 28 references indexed in Scilit:
- US Renal Data System 2011 Annual Data ReportAmerican Journal of Kidney Diseases, 2012
- 2011 Update on Pancreas Transplantation: Comprehensive Trend Analysis of 25,000 Cases Followed Up Over the Course of Twenty-Four Years at the International Pancreas Transplant Registry (IPTR)The Review of Diabetic Studies, 2011
- Cardiovascular and Noncardiovascular Mortality Among Patients Starting DialysisJAMA, 2009
- One Thousand Simultaneous Pancreas-Kidney Transplants at a Single Center With 22-Year Follow-UpAnnals of Surgery, 2009
- Incidence and Predictors of Myocardial Infarction after Kidney TransplantationJournal of the American Society of Nephrology, 2005
- Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5‐yr follow‐upClinical Transplantation, 2004
- Lessons Learned From More Than 1,000 Pancreas Transplants at a Single InstitutionAnnals of Surgery, 2001
- Long-term survival in renal transplant recipients with graft functionKidney International, 2000
- Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric TransplantNew England Journal of Medicine, 1999
- Clinical epidemiology of cardiovascular disease in chronic renal diseaseAmerican Journal of Kidney Diseases, 1998